All In MedTech

Device Trial Radar · NCT05785949

Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair

A Prospective, Multicenter, Randomized, Parallel Controlled Study Evaluating the Safety and Efficacy of Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair

Last checked: Nov 20, 2026Latest source record: Mar 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

75

Actual

Start

Mar 10, 2023

Primary completion

Dec 4, 2025

Study completion Jan 31, 2026

Sponsor

Lead sponsor
Geistlich Pharma AGNot on our public-company list
Sponsor type
Industry
Collaborators
TigerMed
First posted
Mar 27, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, multicenter, randomized, parallel controlled study evaluating the safety and efficacy of Chondro-Gide® bilayer collagen membrane in knee cartilage defect repair. The objective of this clinical trial is to evaluate the efficacy and safety of Chondro-Gide® bilayer collagen membrane in knee cartilage defect repair

Conditions

  • Cartilage Defects

Interventions

  • MicrofractureProcedure

    Use of standard tool kit to drill vertically from the periphery to the center with a hole spacing of 3\~4 mm with care to prevent penetrating adjacent holes. The hole depth should be 3\~5 mm and fat droplets or blood oozing is seen after loosening the tourniquet. However, no blood oozing is observed in some holes and in such case, the hole depth should be deepened to 5\~7 mm.

  • Chondro-Gide bilayer collagen membraneDevice

    After the Microfracture, the porous layer of the bilayer collagen membrane faces the bone surface. The already trimmed, cut and wetted membrane is insert into the defect and fixed symmetrically with absorbable surgical suture with needle. Knots are put on the pinhole of collagen membrane to avoid tearing of surrounding cartilage or collagen membrane during knotting.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART)Time frame: 24 months postoperative

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Sino-Japanese Friendship Hospital

    Beijing, China

  • Peking University Third Hospital

    Beijing, China

  • The Second Hospital of Jilin University

    Changchun, China

15 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.